Main Presentation: “Preventing Heart Disease and Cognitive Decline” by Dayan Goodenowe, PhD
April 6th, 2023 @ 11am PST
The optimal goal is a goal we all aspire to. What steps, lifestyle changes will get us there? One measure of progress towards unwanted diseases is plamaologens. Dr. Goodenowe will discuss how we can move towards optimal health, measure our progress, and reduce the risks for chronic diseases. Plasmalogens are a class of membrane glycerophospholipids, and a potential therapeutic target for neurodegenerative and cardiometabolic disease.
Join Zoom Meeting
https://us02web.zoom.us/j/88374540576?pwd=N0RqaTZBcUJPVFBTMVE4V2N2dWQ0Zz09
Meeting ID: 883 7454 0576
Passcode: 842532
One tap mobile
+16694449171,,88374540576#,,,,*842532# US
+16699006833,,88374540576#,,,,*842532# US (San Jose)
Dial by your location
+1 669 444 9171 US
+1 669 900 6833 US (San Jose)
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 719 359 4580 US
+1 646 931 3860 US
+1 689 278 1000 US
+1 929 436 2866 US (New York)
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
Meeting ID: 883 7454 0576
Passcode: 842532
Find your local number:
https://us02web.zoom.us/u/kbXtD26SFP
About Dayan Goodenowe, PhD
Founder and CEO, Prodrome Sciences & The Dr. Goodenowe
Research Institute Dr. Goodenowe’s research into the biochemical mechanisms of disease started in 1990.
His curiosity about the biochemistry of life is as insatiable today as it was 30 years ago.
In those 30 years, Dr. Goodenowe invented and developed advanced bioinformatic technologies, designed and manufactured novel supplements, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and numerous cancers.
